Novadaq Technologies Inc.  

(Public, TSE:NDQ)   Watch this stock  
Find more results for NDQ
12.48
0.00 (0.00%)
Delayed:   12:08PM EDT
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 11.79 - 20.40
Open     -
Vol / Avg. 0.00/2,455.00
Mkt cap 690.47M
P/E     -
Div/yield     -
EPS -0.60
Shares 57.43M
Beta 0.68
Inst. own     -
Jul 26, 2016
Q2 2016 Novadaq Technologies Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 21, 2016
Novadaq Technologies Inc at JMP Securities Life Sciences Conference - 1:30PM EDT - Add to calendar
Jun 14, 2016
Novadaq Technologies Inc at William Blair Growth Stock Conference - 3:10PM EDT - Add to calendar
Jun 1, 2016
Novadaq Technologies Inc at Craig-Hallum Institutional Investor Conference Add to calendar
May 24, 2016
Novadaq Technologies Inc at UBS Global Healthcare Conference
May 18, 2016
Novadaq Technologies Inc Annual Shareholders Meeting
May 12, 2016
Novadaq Technologies Inc Annual Shareholders Meeting (Estimated)
May 5, 2016
Novadaq Technologies Inc at Deutsche Bank Health Care Conference
May 3, 2016
Novadaq Technologies Inc at Bloom Burton & Co. Healthcare Investor Conference
Apr 27, 2016
Q1 2016 Novadaq Technologies Inc Earnings Call
  

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -39.38% -48.31%
Operating margin -47.22% -56.47%
EBITD margin - -45.74%
Return on average assets -16.33% -16.54%
Return on average equity -18.97% -20.19%
Employees 56 -
CDP Score - -

Address

5090 Explorer Dr Suite 202
MISSISSAUGA, ON L4W 4T9
Canada
+1-905-6293822 (Phone)
+1-905-6290282 (Fax)

Website links

Description

Novadaq Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's segment is medical devices. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The Company's products include SPY, SPY Elite, LUNA and PINPOINT Imaging Systems, SPY Analysis Toolkit, DermACELL and SPY-Q Case Manager. DermACELL is an Acellular Dermal Matrix (ADM) that is used in breast reconstruction surgeries, as well as in the treatment of diabetic foot and venous stasis ulcers, and chronic non-healing wounds.

Officers and directors

Arun Menawat Ph.D. President, Chief Executive Officer, Director
Roger Deck Chief Financial Officer
Anthony F. Griffiths Independent Non-Executive Chairman of the Board
Patrice E. Merrin Director
Age: 66
Robert S. White Director
Age: 54
Aaron Davidson Independent Director
Age: 46
Harold O. Koch Jr. Independent Director
Age: 59